Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
JAMA|January 22, 2004
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trialBernard R Chaitman, Carl J Pepine, John O Parker, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer's Disease Clinical TrialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortalityMelinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Journal of Alzheimer'S Disease : JAD|June 30, 2025
Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 11, 2007
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trialAmi E Iskandrian, Timothy M Bateman, Luiz Belardinelli, et al.
Journal of the American College of Cardiology|April 20, 2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaBernard R Chaitman, Sandra L Skettino, John O Parker, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trialsGuoqiao Wang, Gary Cutter, Neil P Oxtoby, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipientsHoward J Eisen, Jon Kobashigawa, Anne Keogh, et al.
Pageof 2